Masimo narrows FY24 revenue view to $2.09B from $2.08B-$2.11B, consensus $2.09B

The company said, “Consolidated revenue is expected to be approximately $2,094 million, representing 2% growth on a reported basis and 3% growth on a constant currency basis; Healthcare revenue is expected to be approximately $1,395 million, representing 9% growth on a reported basis and 10% growth on a constant currency basis; Non-healthcare revenue is expected to be approximately $699 million, representing a 10% decline on a reported basis and a 9% decline on a constant currency basis and Non-GAAP earnings per diluted share is expected to be more than $4.10, which represents the high end of our prior guidance range.”